白藜芦醇对博莱霉素诱导的小鼠肺纤维化的作用

来源 :现代医药卫生 | 被引量 : 0次 | 上传用户:fossi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨白藜芦醇(Res)对博莱霉素(BLM)致肺纤维化(PF)的治疗作用。方法:复制小鼠博莱霉素致PF模型,采用光镜观察组织学改变,测定肺组织羟脯氨酸(HyP)、超氧化物歧化酶(SOD)、丙二醛(MDA)以反映肺细胞损伤及PF的程度。结果:Res能显著降低实验性PF小鼠肺组织中Hyp、MDA的含量,显著提高小鼠肺组织的SOD活力。病理组织学检查亦表明,Res能明显改善肺泡炎症程度和PF程度。结论:Res对实验性小鼠PF具有一定的治疗作用。 Objective: To investigate the therapeutic effect of resveratrol (Res) on pulmonary fibrosis (PF) induced by bleomycin (BLM). METHODS: The PF model induced by bleomycin was replicated in mice. The histological changes were observed by light microscope. The lung tissues were determined for hydroxyproline (HyP), superoxide dismutase (SOD) and malondialdehyde (MDA) to reflect the lungs. Cell damage and extent of PF. Results: Res could significantly reduce the content of Hyp and MDA in lung tissue of experimental PF mice, and significantly increase SOD activity in lung tissue of mice. Histopathological examination also showed that Res can significantly improve alveolar inflammation and PF. Conclusion: Res has a certain therapeutic effect on experimental mouse PF.
其他文献
期刊
与微信有关的概念股  微信概念牛股之一波导股份,其最早与微信有关的消息,是今年1月23日某股吧发布的简短消息。其后的24日上午10:50,有一股吧发布《波导股份转型打造forme微信公众服务平台》一文,详尽专业地介绍了波导股份的微我业务,并在股吧中迅速流传。当天午盘开盘4分钟之内,波导股份股价由0.54%的微涨快速封于涨停。  2月7日春节后,在微信红包大热的影响下,微信概念全线发力,波导股份再次
本文通过对荣华二采区10
期刊